Figure 9.OARGscore guided chemotherapy strategies. (A–F) Predicted sensitivity of Ribociclib, Alisertib, Niraparib, Epirubicin, Olaparib, and Axitinib, which were candidate chemotherapeutic agents for low-OARGscore patients. (G–L) Predicted sensitivity of Afatinib, Oxaliplatin, Paclitaxel, 5−Fluorouracil, Dabrafenib and Lapatinib, which were candidate potent drug options for high-OARGscore patients.
